|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-12-24
|
|
pubmed:abstractText |
To examine the involvement of cholecystokinin (CCK) in the basal pancreatic exocrine, we investigated the effect of loxiglumide (CR1505), a CCK1 receptor antagonist, on basal pancreatic exocrine secretion in conscious rats.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1536-4828
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
87-91
|
|
pubmed:dateRevised |
2005-5-13
|
|
pubmed:meshHeading |
pubmed-meshheading:12499923-Amylases,
pubmed-meshheading:12499923-Animals,
pubmed-meshheading:12499923-Hormone Antagonists,
pubmed-meshheading:12499923-Infusions, Intravenous,
pubmed-meshheading:12499923-Islets of Langerhans,
pubmed-meshheading:12499923-Kinetics,
pubmed-meshheading:12499923-Male,
pubmed-meshheading:12499923-Pancreatic Juice,
pubmed-meshheading:12499923-Proglumide,
pubmed-meshheading:12499923-Proteins,
pubmed-meshheading:12499923-Rats,
pubmed-meshheading:12499923-Rats, Sprague-Dawley,
pubmed-meshheading:12499923-Receptor, Cholecystokinin A,
pubmed-meshheading:12499923-Receptors, Cholecystokinin,
pubmed-meshheading:12499923-Wakefulness
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats.
|
|
pubmed:affiliation |
Research Laboratory IV, Pharmaceutical Research Division, Mitsubishi Pharma Corporation, Kanagawa, Japan. Ishizaki.Kaoru@mh.m-pharma.co.jp
|
|
pubmed:publicationType |
Journal Article
|
